Making decisions about complex RA medications is tricky. Patients need information about possible benefits, risks of treatment, and the hassles involving in taking and monitoring therapy. Each option has its own merits and sometimes the right decision depends mainly on what you think is most important.
The RA Shared Decision Making Initiative focuses on discovering new ways to support you in decision making.
In this investigation recently published in the medical journal Patient Education and Counseling we report experiments carefully designed to determine the best way to share information with RA patients about how well a medication slows disease progression.
We use this information to design medication decision guides that communicate most effectively and prepare you to make informed choices about starting a new DMARD.
Read more at the National Library of Medicine website